Back to Journals » Medicolegal and Bioethics » Volume 5

Female genital mutilation and male circumcision: toward an autonomy-based ethical framework

Authors Earp BD

Received 12 March 2015

Accepted for publication 12 May 2015

Published 3 October 2015 Volume 2015:5 Pages 89—104

DOI https://doi.org/10.2147/MB.S63709

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Bethany Spielman

Brian D Earp

Department of History and Philosophy of Science, University of Cambridge, Cambridge, UK

Abstract: The non-therapeutic alteration of children’s genitals is typically discussed in two separate ethical discourses: one for girls, in which such alteration is conventionally referred to as “female genital mutilation” (or FGM), and one for boys, in which it is conventionally referred to as “male circumcision.” The former is typically regarded as objectionable or even barbaric; the latter, benign or beneficial. In this paper, however, I call into question the moral and empirical basis for such a distinction, and I argue that it is untenable. As an alternative, I propose an ethical framework for evaluating such alterations that is based upon considerations of bodily autonomy and informed consent, rather than sex or gender.

Keywords: FGM, circumcision, gender, sexuality, autonomy, consent

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Clinical and ethical perspectives on brain death

Nair-Collins M

Medicolegal and Bioethics 2015, 5:69-80

Published Date: 11 September 2015

Olaparib in the management of ovarian cancer

Bixel K, Hays JL

Pharmacogenomics and Personalized Medicine 2015, 8:127-135

Published Date: 7 August 2015

p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression

Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX

OncoTargets and Therapy 2015, 8:1863-1869

Published Date: 24 July 2015

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M

OncoTargets and Therapy 2015, 8:1149-1156

Published Date: 22 May 2015

Cervical cancer screening in Nepal: ethical considerations

Gyawali B, Keeling J, van Teijlingen E, Dhakal L, Aro AR

Medicolegal and Bioethics 2015, 5:1-6

Published Date: 16 January 2015

Brachytherapy in the treatment of cervical cancer: a review

Banerjee R, Kamrava M

International Journal of Women's Health 2014, 6:555-564

Published Date: 28 May 2014

Palliative nursing care for children and adolescents with cancer

Foster TL, Bell CJ, McDonald CF, Harris JS, Gilmer MJ

Nursing: Research and Reviews 2012, 2:17-25

Published Date: 15 June 2012

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update

Schneider RE, Barakat AY, Pippen JE, Osborne CR

Breast Cancer: Targets and Therapy 2011, 3:113-125

Published Date: 4 October 2011

Multidisciplinary care in pediatric oncology

Cantrell MA, Ruble K

Journal of Multidisciplinary Healthcare 2011, 4:171-181

Published Date: 30 May 2011